Management of drug-eluting stent restenosis

Journal of Invasive Cardiology

Volumn 24, Issue 4, 2012, Pages 178-182

  Ishikawa, Kiyotake ^a,b   Aoyama, Yutaka ^a   Hirayama, Haruo ^a  

^a NAGOYA DAINI RED CROSS HOSPITAL   (Japan)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

CABG versus PCI; coronary interventions; in stent restenosis; stenting

Indexed keywords

ANTITHROMBOCYTIC AGENT; EVEROLIMUS; PACLITAXEL; POLYMER; RAPAMYCIN;

ANGIOCARDIOGRAPHY; AORTA BIFURCATION; BARE METAL STENT; BRACHYTHERAPY; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY RECANALIZATION; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG ELUTING STENT; DRUG HYPERSENSITIVITY; DRUG SAFETY; FRACTURE; HEART INFARCTION; HUMAN; IMPLANTATION; IN-STENT RESTENOSIS; INTRAVASCULAR ULTRASOUND; LEFT CORONARY ARTERY; MATERIAL COATING; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PLAIN OLD BALLOON ANGIOPLASTY; PRACTICE GUIDELINE; PROGNOSIS; RECURRENT DISEASE; REVIEW; RISK FACTOR; STENT FRACTURE; STENT THROMBOSIS; TREATMENT FAILURE; TREATMENT INDICATION; TREATMENT OUTCOME;

ANGIOPLASTY, BALLOON; ANGIOPLASTY, BALLOON, CORONARY; BRACHYTHERAPY; CORONARY ARTERY BYPASS; CORONARY RESTENOSIS; DISEASE MANAGEMENT; DRUG-ELUTING STENTS; HUMANS; METALS; PLATELET AGGREGATION INHIBITORS; STENTS;

EID: 84864331597     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Review

References (44)

1. Whan Lee C, Kim SH, Suh J, et al. Long-term clinical outcomes after sirolimus-eluting stent implantation for treatment of restenosis within bare-metal versus drug-eluting stents. Catheter Cardiovasc Interv. 2008;71(5):594-598. (Pubitemid 351550393)
2. Steinberg DH, Gaglia MA Jr, Pinto Slottow TL, et al. Outcome differences with the use of drug-eluting stents for the treatment of in-stent restenosis of bare-metal stents versus drug-eluting stents. Am J Cardiol. 2009;103(4):491-495.
3. Ribamar Costa J, Sousa AG, Moreira A, et al. Comparison of the very long term (1 year) outcomes of drug-eluting stents for the treatment of bare-metal and drug-eluting stent restenosis. EuroIntervention. 2009;5(4):448-453.
4. Costa MA. Treatment of drug-eluting stent restenosis. Am Heart J. 2007;153(4):447-449. (Pubitemid 46440702)
5. Morice MC, Serruys PW, Sousa JE, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med. 2002;346(23):1773-1780. (Pubitemid 34586912)
6. Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003;349(14):1315-1323. (Pubitemid 37186209)
7. Epstein AJ, Polsky D, Yang F, et al. Coronary revascularization trends in the United States, 2001-2008. JAMA. 2011;305(17):1769-1776.
8. Moussa ID, Moses JW, Kuntz RE, et al. The fate of patients with clinical recurrence after sirolimus-eluting stent implantation (a two-year follow-up analysis from the sirius trial). Am J Cardiol. 2006;97:(11)1582-1584. (Pubitemid 43737020)
9. Lemos PA, van Mieghem CA, Arampatzis CA, et al. Post-sirolimus-eluting stent restenosis treated with repeat percutaneous intervention: Late angiographic and clinical outcomes. Circulation. 2004;109(21):2500-2502. (Pubitemid 38720546)
10. Kim YH, Lee BK, Park DW, et al. Comparison with conventional therapies of repeated sirolimus-eluting stent implantation for the treatment of drug-eluting coronary stent restenosis. Am J Cardiol. 2006;98(11):1451-1454.
11. Sheiban I, Sillano D, Biondi-Zoccai G, et al. Incidence and management of restenosis after treatment of unprotected left main disease with drug-eluting stents 70 restenotic cases from a cohort of 718 patients: Fails (failure in left main study). J Am Coll Cardiol. 2009;54(13):1131-1136.
12. Kim KH, Kim DI, Kim IH, et al. Therapeutic strategy for in-stent restenosis based on the restenosis pattern after drug-eluting stent implantation. Korean Circ J. 2009;39(10):408-413.
13. Mishkel GJ, Moore AL, Markwell S, et al. Long-term outcomes after management of restenosis or thrombosis of drug-eluting stents. J Am Coll Cardiol. 2007;49(2):181-184. (Pubitemid 46054395)
14. Sardella G, Colantonio R, De Luca L, et al. Comparison between balloon angioplasty and additional coronary stent implantation for the treatment of drug-eluting stent restenosis: 18-month clinical outcomes. J Cardiovasc Med (Hagerstown). 2009;10(6):469-473.
15. Liistro F, Fineschi M, Grotti S, et al. Long-term clinical outcome of alternative treatment strategies for drug-eluting stents restenosis. EuroIntervention. 2009;5(4):454-459.
16. Chatani K, Muramatsu T, Tsukahara R, et al. Predictive factors of re-restenosis after repeated sirolimus-eluting stent implantation for SES restenosis and clinical outcomes after percutaneous coronary intervention for SES restenosis. J Interv Cardiol. 2009;22(4):354-361.
17. Garg S, Smith K, Torguson R, et al. Treatment of drug-eluting stent restenosis with the same versus different drug-eluting stent. Catheter Cardiovasc Interv. 2007;70(1):9-14. (Pubitemid 47039112)
18. Lee SS, Price MJ, Wong GB, et al. Early- and medium-term outcomes after paclitaxel-eluting stent implantation for sirolimus-eluting stent failure. Am J Cardiol. 2006;98(10):1345-1348. (Pubitemid 44666642)
19. Solinas E, Dangas G, Kirtane AJ, et al. Angiographic patterns of drug-eluting stent restenosis and one-year outcomes after treatment with repeated percutaneous coronary intervention. Am J Cardiol. 2008;102(3):311-315.
20. Cosgrave J, Melzi G, Corbett S, et al. Repeated drug-eluting stent implantation for drug-eluting stent restenosis: The same or a different stent. Am Heart J. 2007;153(3):354-359. (Pubitemid 46328767)
21. Tagliareni F, La Manna A, Saia F, et al. Long-term clinical follow-up of drug-eluting stent restenosis treatment: Retrospective analysis from two high volume catheterisation laboratories. EuroIntervention. 2010;5(6):703-708.
22. Singh IM, Filby SJ, Sakr FE, et al. Clinical outcomes of drug-eluting versus bare-metal in-stent restenosis. Catheter Cardiovasc Interv. 2010;75(3):338-342.
23. Rathore S, Kinoshita Y, Terashima M, et al. A comparison of clinical presentations, angiographic patterns and outcomes of in-stent restenosis between bare-metal stents and drug-eluting stents. EuroIntervention. 2010;5(7):841-846.
24. Mehilli J, Byrne RA, Tiroch K, et al. Randomized trial of paclitaxel- versus sirolimus-eluting stents for treatment of coronary restenosis in sirolimus-eluting stents: The ISAR-DESIRE 2 (intracoronary stenting and angiographic results: Drug-eluting stents for in-stent restenosis 2) study. J Am Coll Cardiol. 2010;55(24):2710-2716.
25. Kastrati A, Mehilli J, von Beckerath N, et al. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: A randomized controlled trial. JAMA. 2005;293(2):165-171. (Pubitemid 40095867)
26. Alfonso F, Perez-Vizcayno MJ, Hernandez R, et al. Sirolimus-eluting stents versus bare-metal stents in patients with in-stent restenosis: Results of a pooled analysis of two randomized studies. Catheter Cardiovasc Interv. 2008;72(4):459-467.
27. Stone GW, Ellis SG, O'Shaughnessy CD, et al. Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: The TAXUS V ISR randomized trial. JAMA. 2006;295(11):1253-1263.
28. Kedhi E, Joesoef KS, McFadden E, et al. Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): A randomised trial. Lancet. 2010;375(9710):201-209.
29. Aminian A, Kabir T, Eeckhout E. Treatment of drug-eluting stent restenosis: An emerging challenge. Catheter Cardiovasc Interv. 2009;74(1):108-116.
30. Scheller B, Hehrlein C, Bocksch W, et al. Two year follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. Clin Res Cardiol. 2008;97(10):773-781.
31. Vaquerizo B, Serra A, Miranda-Guardiola F, et al. One-year outcomes with angiographic follow-up of paclitaxel-eluting balloon for the treatment of in-stent restenosis: Insights from Spanish multicenter registry. J Interv Cardiol. 2011;24(6):518-528.
32. Serruys PW, Morice MC, Kappetein AP, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009;360(10):961-972.
33. Torguson R, Sabate M, Deible R, et al. Intravascular brachytherapy versus drug-eluting stents for the treatment of patients with drug-eluting stent restenosis. Am J Cardiol. 2006;98(10):1340-1344.(Pubitemid 44666639)
34. Feres F, Munoz J, Abizaid A, et al. Angiographic and intravascular ultrasound findings of the late catch-up phenomenon after intracoronary beta-radiation for the treatment of in-stent restenosis. J Invasive Cardiol. 2005;17(9):473-477.
35. Waksman R, Ajani AE, White RL, et al. Five-year follow-up after intracoronary gamma radiation therapy for in-stent restenosis. Circulation. 2004;109(3):340-344. (Pubitemid 38133901)
36. Adamian M, Colombo A, Briguori C, et al. Cutting balloon angioplasty for the treatment of in-stent restenosis: A matched comparison with rotational atherectomy, additional stent implantation and balloon angioplasty. J Am Coll Cardiol. 2001;38(3):672-679. (Pubitemid 32835734)
37. Mehran R, Dangas G, Abizaid AS, et al. Angiographic patterns of in-stent restenosis: Classification and implications for long-term outcome. Circulation. 1999;100(18):1872-1878. (Pubitemid 29511140)
38. Corbett SJ, Cosgrave J, Melzi G, et al. Patterns of restenosis after drug-eluting stent implantation: Insights from a contemporary and comparative analysis of sirolimus- and paclitaxel-eluting stents. Eur Heart J. 2006;27(19):2330-2337. (Pubitemid 44453577)
39. Dangas GD, Claessen BE, Caixeta A, et al. In-stent restenosis in the drug-eluting stent era. J Am Coll Cardiol. 2010;56(23):1897-1907.
40. Aoki J, Nakazawa G, Tanabe K, et al. Incidence and clinical impact of coronary stent fracture after sirolimus-eluting stent implantation. Catheter Cardiovasc Interv. 2007;69(3):380-386. (Pubitemid 46339279)
41. Kandzari DE, Rao SV, Moses JW, et al. Clinical and angiographic outcomes with sirolimus-eluting stents in total coronary occlusions: The ACROSS/TOSCA-4 (approaches to chronic occlusions with sirolimus-eluting stents/total occlusion study of coronary arteries-4) trial. JACC Cardiovasc Interv. 2009;2(2):97-106.
42. Stone GW, Ellis SG, Cannon L, et al. Comparison of a polymer-based paclitaxel-eluting stent with a bare-metal stent in patients with complex coronary artery disease: A randomized controlled trial. JAMA. 2005;294(10):1215-1223. (Pubitemid 41352109)
43. Kushner FG, Hand M, Smith SC Jr, et al. 2009 focused updates: ACC/AHA guidelines for the management of patients with st-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update): A report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. Circulation. 2009;120(22):2271-2306.
44. Lee SW, Park SW, Kim YH, et al. Drug-eluting stenting followed by cilostazol treatment reduces late restenosis in patients with diabetes mellitus the DECLARE-DIABETES trial (a randomized comparison of triple antiplatelet therapy with dual antiplatelet therapy after drug-eluting stent implantation in diabetic patients). J Am Coll Cardiol. 2008;51(12):1181-1187.